Cited by 157Cancer survivorship and careHealth Systems, Economic Evaluations, Quality of LifeHealth Education and Validation

The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30

Open access
GUZELANT, A., GOKSEL, T., OZKOK, S., TASBAKAN, S., AYSAN, T., BOTTOMLEY, A.·2004·European Journal of Cancer Care

Abstract

The Turkish version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire version 2.0 (EORTC QLQ-C30 v.2.0) has started to be used in clinical trials recently. The objective of the study was to evaluate the validity and reliability of the Turkish version of the EORTC QLQ-C30 v.2.0 and the correlation between the Karnofsky Performance Scale (KPS) and the EORTC QLQ-C30. Two hundred and two lung cancer patients were included in the study between January and March 2000. All the subscales met the minimal standards of reliability (Cronbach's alpha > or = 0.70). Only the role functioning scale differed among the three disease stages of patients (local, locoregional and metastatic). There was no statistically significant difference among therapy types. All interscale correlations were statistically significant (P < 0.01). The strongest correlations were found among the physical functioning, role functioning and fatigue scales. Social functioning was closely related with physical, role, emotional and cognitive functioning. The weakest correlations were between nausea/vomiting and the other scales. Global quality of life (QOL) was substantially correlated with most of the scales except cognitive functioning. The coefficients for the correlation between the items differed between 0.12 and 0.97 and all the subscales were strongly correlated with the scales which they formed. The highest correlation between the EORTC QLQ-C30 and KPS was for physical functioning (r = 0.62, P < 0.05). The Turkish version of the EORTC QLQ-C30 is a valid (by means of interscales validity) and reliable instrument for Turkish lung cancer patients and can be used in clinical studies but needs supporting by the reference data on the QOL of the Turkish population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2354.2003.00435.x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Review.
  2. Nunnally J.C. (1978) Psychometric Theory, 2nd edn. McGraw- Hill, New York.
  3. Slevin M.L., Plant H., Lynch D., Drinkwater J. & Gregory W.M. (1988) Who should measure quality of life, the doctors or the patient? British Journal of Cancer 57, 287-295.

Authors
GUZELANT, A., GOKSEL, T., OZKOK, S., TASBAKAN, S., AYSAN, T., & BOTTOMLEY, A.
Affiliations
  • Ege University (TR)
  • European Organisation for Research and Treatment of Cancer (BE)
Venue
European Journal of Cancer Care
Publisher
Wiley
Published
2004-05
Volume
13
Issue
2
Pages
135-144
ISSN
  • 0961-5423 (ISSN-L)
  • 1365-2354
OpenAlex
W2077642133
Cited by
157
References
33
Citations by year
2026: 6 · 2025: 7 · 2024: 18 · 2023: 10 · 2022: 9 · 2021: 17 · 2020: 14 · 2019: 9 · 2018: 6 · 2017: 9 · 2016: 8 · 2015: 6 · 2014: 4 · 2013: 2 · 2012: 2
FWCI
0.96
Type
journal article
Language
en
Open access
Locations
  • European Journal of Cancer Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Education › Health Education and Validation
Keywords
EORTC QLQ-C30, Turkish translation, cross-cultural adaptation, quality of life, lung cancer, Karnofsky performance status, psychometric validation, reliability statistics, validity, role functioning, physical function, fatigue, social functioning
MeSH terms
Activities of Daily Living, Adult, Aged, Aged, 80 and over, Female, Health Status Indicators, Humans, Lung Neoplasms, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Sensitivity and Specificity, Turkey, Karnofsky Performance Status, Sickness Impact Profile

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review